Antihyperglycemic Effects of Fruits of Privet (Ligustrum obtusifolium) in Streptozotocin-Induced Diabetic Rats Fed a High Fat Diet

Journal of Medicinal Food

Volumn 12, Issue 1, 2009, Pages 109-117

  Lee, Sang Il ^a   Oh, Sung Hee ^b   Park, Kun Young ^c   Park, Bum Ho ^d   Kim, Jeong Sook ^a   Kim, Soon Dong ^d  

^a Keimyung College University   (South Korea)

^b Pohang College   (South Korea)

^c Pusan National University   (South Korea)

^d Catholic University of Daegu   (South Korea)

Author keywords

Blood glucose; Diabetes; High fat diet; Insulin; Ligustrum obtusifolium; Privet; Reactive oxygen species generating and scavenging enzymes; Streptozotocin

Indexed keywords

ANTIDIABETIC AGENT; FRUCTOSAMINE; GLUCOSE; GLUTATHIONE TRANSFERASE; INSULIN; LIGUSTRUM OBTUSIFOLIUM EXTRACT; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG; XANTHINE OXIDASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DEATH; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG EFFECT; ENZYME ACTIVITY; FLUID INTAKE; FOOD INTAKE; GLUCOSE BLOOD LEVEL; INSULIN BLOOD LEVEL; LIGUSTRUM OBTUSIFOLIUM; LIPID DIET; NONHUMAN; OLEACEAE; PANCREAS ISLET BETA CELL; PANCREAS ISLET DELTA CELL; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES; WEIGHT GAIN;

ALANINE TRANSAMINASE; ANIMALS; BIOLOGICAL MARKERS; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; DIETARY FATS; FRUCTOSAMINE; FRUIT; GLUTATHIONE; GLUTATHIONE TRANSFERASE; HYPOGLYCEMIC AGENTS; INSULIN; KIDNEY; LIGUSTRUM; MALE; ORGAN SIZE; PANCREAS; PHYTOTHERAPY; PLANT PREPARATIONS; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; SUPEROXIDE DISMUTASE; WEIGHT GAIN; XANTHINE OXIDASE;

ANIMALIA; LIGUSTRUM OBTUSIFOLIUM; RATTUS;

EID: 64949202533     PISSN: 1096620X     EISSN: None     Source Type: Journal    
DOI: 10.1089/jmf.2007.0000     Document Type: Article

References (47)

1. Annual Report on the Cause of Death Statistics. Korea National Statistical Office 21, Seoul, 2002.
2. Rizza RA, Cryer PE, Gerich JE: Role of glucagon, catecholamine, and growth hormone in human glucose counterregulation. J Clin Invest 1979;64:62-71.
3. American Diabetes Association: Diagnosis and classification of diabetes mellitus. Diabetes Care 2006;29(Suppl 1):S43-S48.
4. Randle PJ, Garland PB, Hales CN: The glucose-fatty acid cycle: its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1963;1:785-789.
5. Bevilacqua S, Bonadonna R, Bizzigori G, Boni C, Ciociaro D, Maccari F, Giorico MA, Ferrannini E: Acute elevation of free fatty acid levels leads to hepatic insulin resistance in obese subjects. Metab Clin Exp 1987;36:502-506.
6. Storlien LH, Jenkins AB, Chisholm DJ, Pascoe WS: Influence of dietary fat composition on development of insulin resistance in rats. Diabetes 1991;40:280-289.
7. Choe WK, Yoon OH, Kang BT: Effects of n-3 polyunsaturated fatty acids on glucose uptake of soleus muscle in NIDDM diabetes rats. Korean J Food Nutr 1998;11:550-555.
8. Koya D, King GL: Protein kinase C activation and the development of diabetic complications. Diabetes 1998;47:859-866.
9. Evans JL, Goldfine ID, Maddux BA, Grodsky GM: Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocr Rev 2002;23:599-622.
10. Nakamura Y, Saitoh S, Takagi S, Ohnishi H, Chiba Y, Kato N, Akasaka H, Miura T, Tsuchihashi K, Shimamoto K: Impact of abnormal glucose tolerance, hypertension and other risk factors on coronary artery disease. Circ J 2007;71:20-25.
11. Koivisto VA: Insulin therapy in type II diabetes. Diabetes Care 1993;16:29-39.
12. Yook CS: Coloured Medicinal Plants of Korea. Academybook, Seoul, 1989, p. 435.
13. Lee JH, Chang SY, Yook CS: Studies on the morphology and components of Ligustrum obtusifolium and other Ligustrum spp. Bull KH Pharma Sci 1999;27:21-30.
14. Konno K, Hirayama C, Yasui H, Nakamuta M: Enzymatic activation of oleuropein: a protein crosslinker used as a chemical defense in the privet tree. Proc Natl Acad Sci U S A 1999;96: 9159-9164.
15. Andreadou I, Iliodromitis EK, Mikros E, Constantinou M, Agalias A, Magiatis P, Skaltsounis AL, Kamber E, Rsantili-Kakoulidou A, Kremastinos DT: The olive constituent oleuropein exhibits anti-ischemic, antioxidative, and hypolipidemic effects in anesthetized rabbits. J Nutr 2006;136:2213-2219.
16. Al-Azzawie HF, Alhamdani MS: Hypoglycemic and antioxidant effect of oleuropein in alloxan-diabetic rabbits. Life Sci 2006;78: 1371-1377.
17. Hamdi HK, Castellon R: Oleuropein, a non-toxic olive iridoid, is an anti-tumor agent and cytoskeleton disruptor. Biochem Biophys Res Commun 2005;334:769-778.
18. He ZD, But Paul PH, Chan TW Dominic, Dong H, Xu HX, Lau CP, Sun HD: Antioxidative glucosides from the fruits of Ligustrum lucidum. Chem Pharm Bull 2001;49:780-784.
19. Wang Q, Fan M, Bian Z, Nie M, Chen Z: Extract and identify ingredient from Ligustrum lucidum Ait and study its effect to periodontal pathogen. Zhonghua Kou Qiang Yi Xue Za Zhi 2002;37: 388-390.
20. Yim YK, Wu WK, Pak WF, Ko KM: Hepatoprotective action of an oleanolic acid-enriched extract of Ligustrum lucidum fruits is mediated through an enhancement on hepatic glutathione regeneration capacity in mice. Phytother Res 2001; 15:589-592.
21. Ma SC, He ZD, Deng XL, But Paul PH, Ooi Vincent EC, Xu HX, Lee Spencer HS, Lee SF: In vitro evaluation of secoiridoid glucosides from the fruits of Ligustrum lucidum as antiviral agents. Chem Pharm Bull (Tokyo) 2001;49:1471-1473.
22. Niikawa M, Hayashi H, Sato T, Nagase H, Kito H: Isolation of substance from glossy privet (Ligustrum lucidum Ait.) inhibiting the mutagenicity of benzópyrene in bacteria. Mutat Res 1993;319: 1-9.
23. Nagy M, Spiková J, Vrchovská V, Kontšeková Z, Šeršeň F, Mučaji P, Grančai D: Free radical scavenging activity of different extracts and some constituents from the leaves of Ligustrum vulgare and L. delavayanum. Fitoterapia 2006;77:395-397.
24. Lau KM, He ZD, Dong H, Fung KP, But PP: Anti-oxidative, antiinflammatory and hepato-protective effects of Ligustrum robustun. J Ethnopharmacol 2002;83:63-71.
25. Liu H, Shi Y, Wang D, Yang G, Yu A, Zhang H: MECC determination of oleanolic acid and ursolic acid isomers in Ligustrum lucidum Ait. J Pharm Biomed Anal 2003;32:479-485.
26. Altinier G, Sosa S, Aquino RP, Mencherini T, Della Loggia R, Tubaro A: Characterization of topical antiinflammatory compounds in Rosmarinus officinalis L. J Agric Food Chem 2007;55: 1718-1723.
27. Senthil S, Chandramoha G, Pugalendi KV: Isomers (oleanolic and ursolic acids) differ in their protective effect against isoproterenol-induced myocardial ischemia in rats. Int J Cardiol 2007;119:131-133.
28. Somova LO, Nadar A, Rammanan P, Shode FO: Cardiovascular, antihyperlipidemic and antioxidant effects of oleanolic and ursolic acids in experimental hypertension. Phytomedicine 2003;10: 115-121.
29. Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of the low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 1972;18: 499-502.
30. Habig WH, Pabist MJ, Jakoby WB: Glutathione S-transferase: the first enzymatic step in mercapturic acid formation. J Biol Chem 1974;249:7130-7139.
31. Martin JP, Dailey JM, Sugarmanand E: Negative and positive assays of superoxide dismutase based on hematoxylin autoxidation. Arch Biochem Biophys 1987;255:329-336.
32. Stirpe F, Della Corte E: The regulation of rat liver xanthine oxidase. Conversion in vitro of the enzyme activity from dehydrogenase (type D) to oxidase (type O). J Biol Chem 1969;244: 3855-3860.
33. Ellman GL: Tissue sulfhydryl group. Arch Biochem Biophys 1959; 82:70-77.
34. Satho K: Serum lipid peroxide in cerebrovascular disorders determined by a new colorimetric method. Clin Chim Acta 1978; 90:37-43.
35. Lowry OH, Rosebrough NJ, Farr AL, Randall RL: Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193: 265-275.
36. rd ed. W.B. Saunders, Philadelphia, 1976, p. 1031.
37. th ed. (Kumar V, Abbas AK, Fausto N, eds.). Elsevier Saunders, Philadelphia, 2005, pp. 1155-1226.
38. Wu YG, Xia LL, Lin H, Zhou D, Qian H, Lin ST: Prevention of early liver injury by breviscapine in streptozotocin-induced diabetic rats. Planta Med 2007;73:433-438.
39. Meier M, Park JK, Overheu D, Kirsch T, Lindschau C, Gueler F, Leitages M, Menne J, Haller H: Deletion of protein kinase C-beta isoform in vivo reduces renal hypertrophy but not albuminuria in the streptozotocin-induced diabetic mouse model. Diabetes 2007;56:346-354.
40. Liu J: Pharmacology of oleanolic acid and ursolic acid. J Ethnopharmacol 1995;49:57-68.
41. De Ritis R, Giusti G, Piccinino F, Cacciatore L: Biochemical laboratory tests in viral hepatitis and other hepatic diseases: evaluation and follow-up. Bull WHO 1965;32:59-72.
42. Del Maestro RF: An approach to free radicals in medicine and biology. Acta Physiol Scand 1980;492:153-168.
43. Kaur G, Alam MS, Jabbar Z, Javed K, Athar M: Evaluation of antioxidant activity of Cassia siamea flowers. J Ethnopharmacol 2006;108:340-348.
44. Harrison R: Structure and function of xanthine oxidoreductase: where are we now? Free Radic Biol Med 2002;33:774-749.
45. Desco MC, Asensi M, Marquez R, Martinez-Valls J, Vento M, Pallardo FV, Sastre J, Vina J: Xanthine oxidase is involved in free radical production in type 1 diabetes: protection by allopurinol. Diabetes 2002;51:1118-1124.
46. Chasseaud LF: The role of glutathione and glutathione S-transferase in the metabolism of chemical carcinogens and other electrophilic agents. Adv Cancer Res 1979;29: 175-274.
47. Sharma R, Yang Y, Sharma A, Awasthi S, Awasthi YC: Antioxidant role of glutathione S-transferase: protection against oxidant toxicity and regulation of stress-mediated apoptosis. Antioxid Redox Signal 2004;6:289-300.